Dali Pharmaceuticalco.,Ltd

Shanghai Stock Exchange 603963.SS

Dali Pharmaceuticalco.,Ltd Dividend Yield on January 14, 2025: 0.42%

Dali Pharmaceuticalco.,Ltd Dividend Yield is 0.42% on January 14, 2025, a 543.08% change year over year. Dividend yield measures the dividend per share relative to stock's price value; higher yield suggests higher dividend return.

Dali Pharmaceuticalco.,Ltd 52-week high Dividend Yield is 0.42% on January 14, 2025, which is 0.00% below the current Dividend Yield.
Dali Pharmaceuticalco.,Ltd 52-week low Dividend Yield is 0.05% on March 21, 2024, which is -88.76% below the current Dividend Yield.
Dali Pharmaceuticalco.,Ltd average Dividend Yield for the last 52 weeks is 0.20%.

Key data

Date	Dividend Yield	Free Cash Flow Yield	Earnings Yield	Enterprise Value (EV)

Shanghai Stock Exchange: 603963.SS

Dali Pharmaceuticalco.,Ltd

CEO	Mr. Jun Xiang Yang
IPO Date	Sept. 22, 2017
Location	China
Headquarters	No. 118, West Huancheng Road
Employees	272
Sector	Health Care
Industries Pharmaceuticals

Description

Dali Pharmaceuticalco.,Ltd researches, develops, produces, and sells pharmaceutical products in China. It develops Chinese and Western medicine injection products of 20 varieties with 44 specifications of the injection drug approval number. The company's products include xingnaojing, shenmai, and astragalus injections, as well as leucocin A and citicoline injections. It also has 31 patents, including 11 invention patents, 16 utility models, and 3 design patents. The company was founded in 1996 and is headquartered in Dali, China.

Key trends

Past 5 years